NBN and precursor B-cell acute lymphoblastic leukemia: Of the 25 B-ALL-related NBN variants in our cohort, only four variants (16%) are classified as benign or pathogenic as reported in the ClinVar database, with the remaining 21 variants (84%) noted as “of uncertain significance” (Table 1).